Finance

Lists
8RP:FRA
Celon Pharma SA
€4,18
-1,41%
(-0,060) 1D
30 Sep., 08:22:14 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8RP...
Open
€4,18
High
€4,18
Low
€4,18
Mkt. cap
1,01 mjd
Avg. vol.
8,00
Volume
0,00
52-wk high
€5,77
52-wk low
€4,18
No. of employees
560
Open
€4,18
High
€4,18
Low
€4,18
Mkt. cap
1,01 mjd
Avg. vol.
8,00
Volume
0,00
52-wk high
€5,77
52-wk low
€4,18
No. of employees
560
About Celon Pharma SA
CEO-
Employees560
Founded2002
Headquarters-
SectorPharmaceutical industry
Websitecelonpharma.com
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
55,82 m
71,13 m
66,67 m
61,29 m
Cost of goods sold
20,26 m
16,83 m
11,54 m
16,70 m
Cost of revenue
20,26 m
16,83 m
11,54 m
16,70 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35,01 m
33,02 m
35,44 m
36,08 m
Operating expense
52,22 m
46,24 m
52,60 m
50,56 m
Total operating expenses
72,48 m
63,07 m
64,14 m
67,26 m
Operating income
-16,67 m
8,06 m
2,53 m
-5,98 m
Other non operating income
-
-30,00 k
-250,00 k
169,12 m
EBT including unusual items
-26,84 m
-2,77 m
-6,57 m
160,34 m
EBT excluding unusual items
-26,84 m
-2,77 m
-6,57 m
160,34 m
Income tax expense
5,92 m
-6,43 m
18,33 m
-2,26 m
Effective tax rate
-22,05%
232,29%
-279,14%
-1,41%
Other operating expenses
5,98 m
2,20 m
6,37 m
3,36 m
Net income
-32,76 m
3,66 m
-24,90 m
162,60 m
Net profit margin
-58,70%
5,15%
-37,35%
265,30%
Earnings per share
-
-
-
-
Interest and investment income
550,00 k
-
149,00 k
151,00 k
Interest expense
-304,00 k
-
-341,00 k
-497,00 k
Net interest expenses
246,00 k
-
-192,00 k
-346,00 k
Depreciation and amortization charges
11,23 m
11,01 m
10,78 m
11,13 m
EBITDA
-8,28 m
16,34 m
11,40 m
3,44 m
Gain or loss from assets sale
2,53 m
-170,00 k
-2,91 m
-569,00 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme